Resources for Interpreting Variants in Precision Genomic Oncology Applications
Precision genomic oncology—applying high throughput sequencing (HTS) at the point-of-care to inform clinical decisions—is a developing precision medicine paradigm that is seeing increasing adoption. Simultaneously, new developments in targeted agents and immunotherapy, when informed by rich genomic...
Main Authors: | Hsinyi Tsang, KanakaDurga Addepalli, Sean R. Davis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fonc.2017.00214/full |
Similar Items
-
Precision Genomic Practice in Oncology: Pharmacist Role and Experience in an Ambulatory Care Clinic
by: Farah Raheem, et al.
Published: (2020-03-01) -
A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants
by: Xuanyi Li, et al.
Published: (2020-02-01) -
Coordinating an Oncology Precision Medicine Clinic Within an Integrated Health System: Lessons Learned in Year One
by: Michael A. Thompson, et al.
Published: (2019-01-01) -
Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize
by: Michal Kýr, et al.
Published: (2020-03-01) -
The Role of CYP450 Drug Metabolism in Precision Cardio-Oncology
by: Olubadewa A. Fatunde, et al.
Published: (2020-01-01)